Cargando…

The advent of precision therapy in gastrointestinal malignancies: Targeting the human epidermal growth factor receptor family in colorectal and esophagogastric cancer

Until recently, systemic therapy for gastrointestinal malignancies was restricted to relatively noncancer-specific cytotoxic chemotherapy. Over the last 15 years targeted therapies have become available, most notably bevacizumab in the case of advanced colorectal cancer. Unfortunately, there are no...

Descripción completa

Detalles Bibliográficos
Autores principales: Desautels, Danielle, Harlos, Craig, Czaykowski, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4258725/
https://www.ncbi.nlm.nih.gov/pubmed/25525412
http://dx.doi.org/10.4103/1477-3163.145609